First Time Loading...

Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 1.8 CAD Market Closed
Updated: Apr 29, 2024

Wall Street
Price Targets

TH Price Targets Summary
Theratechnologies Inc

Wall Street analysts forecast TH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TH is 6.55 CAD with a low forecast of 4.9 CAD and a high forecast of 8.4 CAD.

Lowest
Price Target
4.9 CAD
172% Upside
Average
Price Target
6.55 CAD
264% Upside
Highest
Price Target
8.4 CAD
367% Upside
Theratechnologies Inc Competitors:
Price Targets
AMGN
Amgen Inc
16% Upside
DTIL
Precision BioSciences Inc
289% Upside
TWST
Twist Bioscience Corp
30% Upside
KRON
Kronos Bio Inc
334% Upside
096530
Seegene Inc
72% Upside
AGEN
Agenus Inc
52% Downside
KURN
Kuros Biosciences AG
192% Upside
HARP
Harpoon Therapeutics Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Theratechnologies Inc

For the last 8 years the compound annual growth rate for Theratechnologies Inc's revenue is 17%. The projected CAGR for the next 3 years is 12%.

17%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Theratechnologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Theratechnologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
45%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TH's stock price target?
Price Target
6.55 CAD

According to Wall Street analysts, the average 1-year price target for TH is 6.55 CAD with a low forecast of 4.9 CAD and a high forecast of 8.4 CAD.

What is Theratechnologies Inc's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Theratechnologies Inc's revenue is 17%. The projected CAGR for the next 3 years is 12%.